Sarepta Therapeutics lays off 493 workers amid FDA probe, stock drop, and concerns over its gene therapy treatment, Elevidys.

U.S. regulators recently asked Sarepta Therapeutics to voluntarily halt shipments of its Elevidys gene therapy after a ...

Sarepta Therapeutics announced it is laying off nearly 500 employees this week, including 80 at its Easton location. According to a mass layoff notice filed with the ...

Sarepta Therapeutics announced a layoff of 493 employees, including 80 in Franklin County, amid restructuring efforts and criticism from the FDA.

A filing with the state details the Columbus job cuts for a biotech cutting more than one-third of its workforce.

Sarepta has also announced an FDA-requested black box warning be included on Elevidys’ label for acute liver injury and failure.

Sarepta Therapeutics announced it has laid off more than one-third of its workforce, a drastic cost-cutting move following the deaths of two teenagers administered its gene therapy for Duchenne ...

Sarepta Therapeutics laid off more than one-third of its workforce, or approximately 500 employees, the company announced Wednesday — a drastic cost-cutting move following the deaths of two ...

COLUMBUS, Ohio (WCMH) — Intel’s CEO reportedly said the company is not in the top 10 semiconductor companies by market cap, fearing it is too far behind to catch up with industry leaders.

What was once only a weekend of tax-free deals in Ohio is now a full two weeks. And it's starting soon. Here's what to know.

Sarepta Therapeutics faces a challenging period as it navigates recent setbacks with its groundbreaking gene therapy, leading to workforce reductions across multiple locations.

Sarepta Therapeutics said it will eliminate 36% of its workforce—approximately 500 jobs—in a restructuring that follows the deaths of two Duchenne muscular dystrophy (DMD) patients following ...